190 related articles for article (PubMed ID: 26035829)
1. MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.
Hartman ML; Talar B; Gajos-Michniewicz A; Czyz M
PLoS One; 2015; 10(6):e0128796. PubMed ID: 26035829
[TBL] [Abstract][Full Text] [Related]
2. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.
Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Hersey P
Mod Pathol; 2007 Apr; 20(4):416-26. PubMed ID: 17384650
[TBL] [Abstract][Full Text] [Related]
3. BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.
Lee EF; Harris TJ; Tran S; Evangelista M; Arulananda S; John T; Ramnac C; Hobbs C; Zhu H; Gunasingh G; Segal D; Behren A; Cebon J; Dobrovic A; Mariadason JM; Strasser A; Rohrbeck L; Haass NK; Herold MJ; Fairlie WD
Cell Death Dis; 2019 Apr; 10(5):342. PubMed ID: 31019203
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
[TBL] [Abstract][Full Text] [Related]
5. The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study.
Beberok A; Rok J; Rzepka Z; Marciniec K; Boryczka S; Wrześniok D
Toxicol In Vitro; 2020 Aug; 66():104884. PubMed ID: 32437906
[TBL] [Abstract][Full Text] [Related]
6. Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.
Tanaka T; Kikuchi N; Goto K; Iino M
Apoptosis; 2016 May; 21(5):594-608. PubMed ID: 26892009
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.
Hartman ML; Talar B; Sztiller-Sikorska M; Nejc D; Czyz M
Oncotarget; 2016 Feb; 7(8):9026-40. PubMed ID: 26824319
[TBL] [Abstract][Full Text] [Related]
8. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
[TBL] [Abstract][Full Text] [Related]
9. Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.
Hlavac M; Dwucet A; Kast RE; Engelke J; Westhoff MA; Siegelin MD; Debatin KM; Wirtz CR; Halatsch ME; Karpel-Massler G
Cell Oncol (Dordr); 2019 Jun; 42(3):287-301. PubMed ID: 30859392
[TBL] [Abstract][Full Text] [Related]
10. Mcl-1 expression and JNK activation induces a threshold for apoptosis in Bcl-xL-overexpressing hematopoietic cells.
Zhang Y; Li X; Tan S; Liu X; Zhao X; Yuan Z; Nie C
Oncotarget; 2017 Feb; 8(7):11042-11052. PubMed ID: 28038464
[TBL] [Abstract][Full Text] [Related]
11. MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL.
Vikström IB; Slomp A; Carrington EM; Moesbergen LM; Chang C; Kelly GL; Glaser SP; Jansen JH; Leusen JH; Strasser A; Huang DC; Lew AM; Peperzak V; Tarlinton DM
Cell Death Dis; 2016 Aug; 7(8):e2345. PubMed ID: 27560714
[TBL] [Abstract][Full Text] [Related]
12. Bcl-xL and Mcl-1 are involved in prevention of in vitro apoptosis in rat late-stage erythroblasts derived from bone marrow.
Asano H; Fukunaga S; Deguchi Y; Kawamura S; Inaba M
J Toxicol Sci; 2012 Feb; 37(1):23-31. PubMed ID: 22293409
[TBL] [Abstract][Full Text] [Related]
13. Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.
Mukherjee N; Lu Y; Almeida A; Lambert K; Shiau CW; Su JC; Luo Y; Fujita M; Robinson WA; Robinson SE; Norris DA; Shellman YG
Oncotarget; 2017 Jul; 8(29):46801-46817. PubMed ID: 27086916
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis.
Ohmer M; Weber A; Sutter G; Ehrhardt K; Zimmermann A; Häcker G
Cell Death Dis; 2016 Aug; 7(8):e2340. PubMed ID: 27537523
[TBL] [Abstract][Full Text] [Related]
15. Mcl-1 and Bcl-xL are essential for survival of the developing nervous system.
Fogarty LC; Flemmer RT; Geizer BA; Licursi M; Karunanithy A; Opferman JT; Hirasawa K; Vanderluit JL
Cell Death Differ; 2019 Aug; 26(8):1501-1515. PubMed ID: 30361616
[TBL] [Abstract][Full Text] [Related]
16. MITF in melanoma: mechanisms behind its expression and activity.
Hartman ML; Czyz M
Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma.
McKee CS; Hill DS; Redfern CP; Armstrong JL; Lovat PE
Exp Dermatol; 2013 Nov; 22(11):767-9. PubMed ID: 24118207
[TBL] [Abstract][Full Text] [Related]
18. Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.
Guo L; Eldridge S; Furniss M; Mussio J; Davis M
Toxicol Appl Pharmacol; 2018 Dec; 360():88-98. PubMed ID: 30268579
[TBL] [Abstract][Full Text] [Related]
19. Mcl-1 and Bcl-x
Hockings C; Alsop AE; Fennell SC; Lee EF; Fairlie WD; Dewson G; Kluck RM
Cell Death Differ; 2018 Mar; 25(4):721-734. PubMed ID: 29459767
[TBL] [Abstract][Full Text] [Related]
20. NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w.
Casanelles E; Gozzelino R; Marqués-Fernández F; Iglesias-Guimarais V; Garcia-Belinchón M; Sánchez-Osuna M; Solé C; Moubarak RS; Comella JX; Yuste VJ
Biochim Biophys Acta; 2013 May; 1833(5):1085-95. PubMed ID: 23369735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
